Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England

View ORCID ProfileHester Allen, View ORCID ProfileElise Tessier, Charlie Turner, Charlotte Anderson, Paula Blomquist, David Simons, Alessandra Løchen, Christopher I Jarvis, Natalie Groves, View ORCID ProfileFernando Capelastegui, Joe Flannagan, Asad Zaidi, Cong Chen, Christopher Rawlinson, Gareth J. Hughes, Dimple Chudasama, View ORCID ProfileSophie Nash, View ORCID ProfileSimon Thelwall, View ORCID ProfileJamie Lopez-Bernal, View ORCID ProfileGavin Dabrera, André Charlett, View ORCID ProfileMeaghan Kall, View ORCID ProfileTheresa Lamagni
doi: https://doi.org/10.1101/2022.02.15.22271001
Hester Allen
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hester Allen
Elise Tessier
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elise Tessier
  • For correspondence: Elise.Tessier{at}phe.gov.uk
Charlie Turner
2Field Service, UK Health Security Agency, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Anderson
2Field Service, UK Health Security Agency, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Blomquist
2Field Service, UK Health Security Agency, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Simons
2Field Service, UK Health Security Agency, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandra Løchen
2Field Service, UK Health Security Agency, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher I Jarvis
2Field Service, UK Health Security Agency, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Groves
3Genomics Cell, UK Health Security Agency, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Capelastegui
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fernando Capelastegui
Joe Flannagan
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asad Zaidi
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cong Chen
2Field Service, UK Health Security Agency, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Rawlinson
2Field Service, UK Health Security Agency, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gareth J. Hughes
2Field Service, UK Health Security Agency, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimple Chudasama
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Nash
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sophie Nash
Simon Thelwall
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon Thelwall
Jamie Lopez-Bernal
4Immunisation and Countermeasures Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jamie Lopez-Bernal
Gavin Dabrera
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gavin Dabrera
André Charlett
5Statistics, Modelling and Economics Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
6Joint Modelling Team, UK Health Security Agency, Porton Down, Salisbury, Wiltshire, SP4 0JG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meaghan Kall
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Meaghan Kall
Theresa Lamagni
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Theresa Lamagni
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Background The SARS-CoV-2 Omicron variant (B.1.1.529) has rapidly replaced the Delta variant (B.1.617.2) to become dominant in England. This epidemiological study assessed differences in transmissibility between the Omicron and Delta using two methods and data sources.

Methods Omicron and Delta cases were identified through genomic sequencing, genotyping and S-gene target failure in England from 5-11 December 2021. Secondary attack rates for Omicron and Delta using named contacts and household clustering were calculated using national surveillance and contact tracing data. We used multivariable logistic regression was used to control for factors associated with transmission.

Findings Analysis of contact tracing data identified elevated secondary attack rates for Omicron vs Delta in household (15.0% vs 10.8%) and non-household (8.2% vs 3.7%) settings. The proportion of index cases resulting in residential clustering was twice as high for Omicron (16.1%) compared to Delta (7.3%). Transmission was significantly less likely from cases, or in named contacts, in receipt of three compared to two vaccine doses in household settings, but less pronounced for Omicron (aRR 0.78 and 0.88) compared to Delta (aRR 0.62 and 0.68). In non-household settings, a similar reduction was observed for Delta cases and contacts (aRR 0.84 and 0.51) but only for Omicron contacts (aRR 0.76, 95% CI: 0.58-0.93) and not cases in receipt of three vs two doses (aRR 0.95, 0.77-1.16).

Interpretation Our study identified increased risk of onward transmission of Omicron, consistent with its successful global displacement of Delta. We identified a reduced effectiveness of vaccination in lowering risk of transmission, a likely contributor for the rapid propagation of Omicron.

Funding Study funded by the UK Health Security Agency.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Study funded by the UK Health Security Agency.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Thank you for submitting your study to the Research Support and Governance Office (RSGO) for review by the PHE Research Ethics and Governance Group (REGG). PHE approval for your study has been granted and you can now start your work in this organisation. This approval is granted based on the information provided in the REGG application form and accompanying study documentation, and on the understanding that the study is conducted in accordance with the conditions stated in the applicable PHE policies and procedures.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data may be available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 17, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
Hester Allen, Elise Tessier, Charlie Turner, Charlotte Anderson, Paula Blomquist, David Simons, Alessandra Løchen, Christopher I Jarvis, Natalie Groves, Fernando Capelastegui, Joe Flannagan, Asad Zaidi, Cong Chen, Christopher Rawlinson, Gareth J. Hughes, Dimple Chudasama, Sophie Nash, Simon Thelwall, Jamie Lopez-Bernal, Gavin Dabrera, André Charlett, Meaghan Kall, Theresa Lamagni
medRxiv 2022.02.15.22271001; doi: https://doi.org/10.1101/2022.02.15.22271001
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
Hester Allen, Elise Tessier, Charlie Turner, Charlotte Anderson, Paula Blomquist, David Simons, Alessandra Løchen, Christopher I Jarvis, Natalie Groves, Fernando Capelastegui, Joe Flannagan, Asad Zaidi, Cong Chen, Christopher Rawlinson, Gareth J. Hughes, Dimple Chudasama, Sophie Nash, Simon Thelwall, Jamie Lopez-Bernal, Gavin Dabrera, André Charlett, Meaghan Kall, Theresa Lamagni
medRxiv 2022.02.15.22271001; doi: https://doi.org/10.1101/2022.02.15.22271001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (431)
  • Allergy and Immunology (757)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13385)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5158)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3276)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14637)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (728)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7512)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)